BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 11526280)

  • 1. Endometrial evaluation with transvaginal US and hysterosonography in asymptomatic postmenopausal women with breast cancer receiving tamoxifen.
    Fong K; Kung R; Lytwyn A; Trudeau M; Chapman W; Nugent P; Glanc P; Manchul L; Szabunio D; Myhr T
    Radiology; 2001 Sep; 220(3):765-73. PubMed ID: 11526280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transvaginal US and hysterosonography in postmenopausal women with breast cancer receiving tamoxifen: correlation with hysteroscopy and pathologic study.
    Fong K; Causer P; Atri M; Lytwyn A; Kung R
    Radiographics; 2003; 23(1):137-50; discussion 151-5. PubMed ID: 12533649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transvaginal hysterosonography: comparison with biopsy in the evaluation of postmenopausal bleeding.
    Dubinsky TJ; Parvey HR; Gormaz G; Curtis M; Maklad N
    J Ultrasound Med; 1995 Dec; 14(12):887-93. PubMed ID: 8583523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transvaginal sonographic and hysteroscopic findings in postmenopausal women receiving tamoxifen.
    Marconi D; Exacoustos C; Cangi B; Perroni A; Zupi E; Valli E; Romanini C
    J Am Assoc Gynecol Laparosc; 1997 May; 4(3):331-9. PubMed ID: 9154782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of transvaginal ultrasonographic and diagnostic hysteroscopic findings in postmenopausal breast cancer patients treated with tamoxifen.
    Gao WL; Zhang LP; Feng LM
    Chin Med J (Engl); 2011 Aug; 124(15):2335-9. PubMed ID: 21933565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow.
    Develioğlu OH; Omak M; Bilgin T; Esmer A; Tüfekçi M
    Gynecol Oncol; 2004 May; 93(2):328-35. PubMed ID: 15099941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy.
    Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Coibion M; Bianco AR;
    Hum Reprod; 2005 Jan; 20(1):294-301. PubMed ID: 15513977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of hysteroscopy and hysterosonography in endometrial abnormalities in asymptomatic postmenopausal women.
    Gumus II; Keskin EA; Kiliç E; Aker A; Kafali H; Turhan NO
    Arch Gynecol Obstet; 2008 Sep; 278(3):241-4. PubMed ID: 18214508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of the progesterone test in screening for endometrial pathology in asymptomatic postmenopausal women receiving treatment with tamoxifen.
    Lubian López DM; Fernandez YG; Rodríguez BR; López FM; Delgado RC
    Menopause; 2010; 17(3):487-93. PubMed ID: 20464783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of transvaginal ultrasonography in the prediction of endometrial pathologies in asymptomatic postmenopausal breast cancer tamoxifen-treated patients.
    Markovitch O; Tepper R; Fishman A; Shapira J; Aviram R; Cohen I
    Gynecol Oncol; 2004 Dec; 95(3):456-62. PubMed ID: 15581946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of sonohysterography in asymptomatic postmenopausal tamoxifen-treated patients.
    Tepper R; Beyth Y; Altaras MM; Zalel Y; Shapira J; Cordoba M; Cohen I
    Gynecol Oncol; 1997 Mar; 64(3):386-91. PubMed ID: 9062139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy.
    McGonigle KF; Shaw SL; Vasilev SA; Odom-Maryon T; Roy S; Simpson JF
    Am J Obstet Gynecol; 1998 Jun; 178(6):1145-50. PubMed ID: 9662294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology.
    Gerber B; Krause A; Reimer T; Mylonas I; Makovitzky J; Kundt G; Janni W
    Clin Cancer Res; 2006 Feb; 12(4):1245-50. PubMed ID: 16489080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study.
    Exacoustos C; Zupi E; Cangi B; Chiaretti M; Arduini D; Romanini C
    Ultrasound Obstet Gynecol; 1995 Dec; 6(6):435-42. PubMed ID: 8903921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen.
    Mourits MJ; Van der Zee AG; Willemse PH; Ten Hoor KA; Hollema H; De Vries EG
    Gynecol Oncol; 1999 Apr; 73(1):21-6. PubMed ID: 10094875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sensitivity and specificity of hysterosonography in endometrial abnormalities in asymptomatic postmenopausal women].
    Tamanaha S; Aldrighi JM; Santos RE; Prado RA
    Rev Assoc Med Bras (1992); 2004; 50(4):427-32. PubMed ID: 15666026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound.
    Gerber B; Krause A; Müller H; Reimer T; Külz T; Makovitzky J; Kundt G; Friese K
    J Clin Oncol; 2000 Oct; 18(20):3464-70. PubMed ID: 11032586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen.
    Fung MF; Reid A; Faught W; Le T; Chenier C; Verma S; Brydon E; Fung KF
    Gynecol Oncol; 2003 Oct; 91(1):154-9. PubMed ID: 14529676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study.
    Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S
    Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of endometrial changes and p53 expression in tamoxifen treated women: comparison of various methods.
    Pokharel HP; Bhatla N; Kriplani A; Mukhopadhyay A; Srivastava A; Ralhan R
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):145-51. PubMed ID: 18603889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.